Biomarker Panel for Alcohol Consumption Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current biomarkers for detecting alcohol consumption lack specificity and sensitivity, failing to accurately distinguish between non-consumption, moderate consumption, and high consumption, and often incorrectly identify non-drinkers or drinkers.

Innovation Solution

A panel of biomarkers including A1BG, A2M, ADIPQ, APOAI, C3, CALCA, CD40, CXCL5, F7, IgE, IGF1, IL2, IL7, CCL3, CCL4, MMP2, KLK3, GOT1, THPO, and VEGFA are assayed in a subject sample to determine alcohol consumption levels, using methods such as immunoassay, gel electrophoresis, mass spectrometry, or nucleic acid assays, allowing for differentiation between consumption levels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If current biomarkers (gamma-glutamyltransferase, carbohydrate deficient transferrin, mean corpuscular volume) are used to detect alcohol consumption, then the detection method is simple and widely available, but the specificity and sensitivity are insufficient leading to false identification of non-drinkers as drinkers and inability to distinguish consumption levels

Engineering Contradiction:
Improvespecificity and sensitivity of alcohol consumption detectionVSAvoidcomplexity of biomarker panel assay
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention segments the detection task by using a panel of multiple individual biomarkers (including gamma-glutamyltransferase, carbohydrate deficient transferrin, mean corpuscular volume, and additional markers) rather than relying on a single biomarker. Each biomarker provides specific information about different aspects of alcohol consumption, and their combined analysis enables differentiation between non-consumption, moderate consumption, and high consumption levels while reducing false positives

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention changes the detection parameters by establishing specific threshold values and reference ranges for each biomarker in the panel. By defining cutoff points and using multivariate analysis of multiple biomarker levels simultaneously, the system achieves higher measurement precision in distinguishing between different consumption states without requiring overly complex diagnostic infrastructure

Inventive Principle:
Principle #35Parameter changes

2Reliability

If a panel of multiple biomarkers is assayed to improve detection accuracy, then the measurement precision and reliability improve, but the device complexity and cost increase

Engineering Contradiction:
Improveaccuracy in identifying non-consumption, moderate consumption and high consumptionVSAvoidcomplexity of assaying multiple biomarkers
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The invention merges multiple individual biomarker assays into a unified panel detection system. By combining the results of several biomarker measurements (gamma-glutamyltransferase, carbohydrate deficient transferrin, mean corpuscular volume, and other markers) into a single integrated assessment, the system achieves high reliability in distinguishing consumption levels while presenting a cohesive diagnostic tool rather than multiple separate tests

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The biomarker panel serves multiple functions simultaneously: it identifies non-consumption, detects moderate consumption, identifies high consumption, and reduces false positives. This multi-functional capability is achieved through the coordinated analysis of multiple biomarkers that collectively provide comprehensive alcohol consumption assessment across different consumption states

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The proposed method effectively detects and characterizes alcohol consumption by accurately identifying non-consumption, moderate consumption, and high consumption, providing a sensitive and specific means to monitor drinking behavior and support alcohol abuse treatment programs.

Implementation Method 1

The biomarkers are assayed by immunoassay

Methodology Applied
Scientific EffectImmunoassay:

Implementation Method 2

The biomarkers are assayed by a combination of gel electrophoresis and mass spectrometry

Methodology Applied
Scientific EffectGel electrophoresis: Electrophoresis

Implementation Method 3

The biomarkers are assayed by a combination of gel electrophoresis and mass spectrometry

Methodology Applied
Scientific EffectMass spectrometry:

Implementation Method 4

The biomarkers are assayed by liquid chromatography, mass spectrometry or a combination of liquid chromatography and mass spectrometry

Methodology Applied
Scientific EffectLiquid chromatography: Chromatography

Data Source

PatentUS8647825B2Compositions and methods relating to monitoring alcohol consumption and alcohol abuse
Publication Date: 2014.02.11 THE PENN STATE RES FOUND INC
  • US8647825B2 patent drawing
  • US8647825B2 patent drawing
  • US8647825B2 patent drawing

AI summary

Methods and compositions according to embodiments of the present invention are provided that specifically and sensitively detect alcohol consumption and whether alcohol consumption is moderate or high in a subject. Aspects of the present invention relate to assays of panels of proteins for detecting non-consumption, moderate consumption and high consumption of ethanol by a subject.